Agid Y - Search Results

1

The density of [125I]-transferrin binding sites on perikarya of melanized neurons of the substantia nigra is decreased in Parkinson's disease.

Faucheux BA, Hauw JJ, Agid Y, Hirsch EC. Faucheux BA, et al. Among authors: agid y. Brain Res. 1997 Feb 21;749(1):170-4. doi: 10.1016/s0006-8993(96)01412-6. Brain Res. 1997. PMID: 9070646

2

Is the vulnerability of neurons in the substantia nigra of patients with Parkinson's disease related to their neuromelanin content?

Kastner A, Hirsch EC, Lejeune O, Javoy-Agid F, Rascol O, Agid Y. Kastner A, et al. Among authors: agid y. J Neurochem. 1992 Sep;59(3):1080-9. doi: 10.1111/j.1471-4159.1992.tb08350.x. J Neurochem. 1992. PMID: 1494900

3

Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson's disease: an in situ hybridization study.

Javoy-Agid F, Hirsch EC, Dumas S, Duyckaerts C, Mallet J, Agid Y. Javoy-Agid F, et al. Among authors: agid y. Neuroscience. 1990;38(1):245-53. doi: 10.1016/0306-4522(90)90389-l. Neuroscience. 1990. PMID: 1979431

4

Microtopography of D1 dopaminergic binding sites in the human substantia nigra: an autoradiographic study.

Thibaut F, Hirsch EC, Raisman R, Javoy-Agid F, Agid Y. Thibaut F, et al. Among authors: agid y. Neuroscience. 1990;37(2):387-98. doi: 10.1016/0306-4522(90)90409-w. Neuroscience. 1990. PMID: 1983469

5

Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.

Hirsch EC, Brandel JP, Galle P, Javoy-Agid F, Agid Y. Hirsch EC, et al. Among authors: agid y. J Neurochem. 1991 Feb;56(2):446-51. doi: 10.1111/j.1471-4159.1991.tb08170.x. J Neurochem. 1991. PMID: 1988548

6

Selective vulnerability of pigmented dopaminergic neurons in Parkinson's disease.

Hirsch EC, Graybiel AM, Agid Y. Hirsch EC, et al. Among authors: agid y. Acta Neurol Scand Suppl. 1989;126:19-22. doi: 10.1111/j.1600-0404.1989.tb01778.x. Acta Neurol Scand Suppl. 1989. PMID: 2575832

7

Characterization of two antigens in parkinsonian Lewy bodies.

Hirsch E, Ruberg M, Portier MM, Dardenne M, Agid Y. Hirsch E, et al. Among authors: agid y. Brain Res. 1988 Feb 16;441(1-2):139-44. doi: 10.1016/0006-8993(88)91391-1. Brain Res. 1988. PMID: 3359227

8

Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.

Faucheux BA, Nillesse N, Damier P, Spik G, Mouatt-Prigent A, Pierce A, Leveugle B, Kubis N, Hauw JJ, Agid Y, et al. Faucheux BA, et al. Among authors: agid y. Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9603-7. doi: 10.1073/pnas.92.21.9603. Proc Natl Acad Sci U S A. 1995. PMID: 7568181 Free PMC article.

9

Does the calcium binding protein calretinin protect dopaminergic neurons against degeneration in Parkinson's disease?

Mouatt-Prigent A, Agid Y, Hirsch EC. Mouatt-Prigent A, et al. Among authors: agid y. Brain Res. 1994 Dec 30;668(1-2):62-70. doi: 10.1016/0006-8993(94)90511-8. Brain Res. 1994. PMID: 7704619

10

Monoamine vesicular uptake sites in patients with Parkinson's disease and Alzheimer's disease, as measured by tritiated dihydrotetrabenazine autoradiography.

Lehéricy S, Brandel JP, Hirsch EC, Anglade P, Villares J, Scherman D, Duyckaerts C, Javoy-Agid F, Agid Y. Lehéricy S, et al. Among authors: agid y. Brain Res. 1994 Oct 3;659(1-2):1-9. doi: 10.1016/0006-8993(94)90856-7. Brain Res. 1994. PMID: 7820649

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

759 results

Search Page

Filters